The global preterm birth diagnostic test kit market is estimated to acquire a valuation of USD 152.2 million by 2024 and attains a value of USD 316.5 million by 2034, reflecting a CAGR of 7.6% between 2024 and 2034.
The preterm birth diagnostic test kit industry is thrust by the growing incidences of preterm births and the requirement for early diagnosis. These kits provide an effective and early screening of prospective preterm births by evaluating biomarkers and clinical standards.
The strengthening cognizance among healthcare professionals and pregnant women, associated with innovations in diagnostic methods, soars preterm birth diagnostic examination kit market expansion. Ongoing research and developments in test kit innovation augment opportunities, targeting at curbing the global strain of premature birth.
A considerable trend is the growing attention to rapid diagnostics. This results in early analysis of preterm birth risk, encouraging healthcare practitioners to make timely decisions and mediations. This trend intensifies the preterm birth diagnostic test equipment adoption.
Regional Outlook:
North America is a key region in the preterm birth diagnostic test kit market. The progressive healthcare infrastructure, research institutes, and high cognizance of prenatal care contribute to a substantial market share in North America. The European countries have advanced healthcare networks and an intense concentration on maternal and fetal health. European countries amplify the demand for diagnostic procedures related to preterm birth.
Asia Pacific ushered by its swift economic progress and an escalating awareness regarding the significance of antenatal care, is witnessing a boom in demand for preterm birth diagnostic kits. The emerging economies with their large populations and enhancing medical care systems, aid considerably to the preterm birth diagnostic test kit demand.
“The preterm birth diagnostic test kit ecosystem indicates optimistic growth potential, escalated by surging consciousness, technological innovations, and evolving healthcare costs. Demand for precise and effective diagnostic solutions soars preterm birth diagnostic examination kit market expansion, with remarkable prospects for advancements and market entry.”, opines an FMI analyst.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!
Key Takeaways:
- The PAMG-1 Test segment in the product type category to grab a share of 62.6% in 2024.
- In the sample type category, the blood segment to clutch a share of 42.2% in 2024.
- China preterm birth diagnostic test kit market exhibit upsurge at CAGR of 10.3% between 2024 and 2034.
- Through 2034, Canada demand revenue of preterm birth diagnostic test kits show escalation at a CAGR of 8.9%.
- From 2024 to 2034, India preterm birth diagnostic test kit market equates at a CAGR of 8.6%.
- Between 2024 and 2034, the United States preterm birth diagnostic examination kit industry imply growth at a CAGR of 8.1%.
- Australia and New Zealand adoption revenue of preterm birth diagnostic examination kits infer a CAGR of 8.1% from 2024 to 2034.
- Poland preterm birth diagnostic test kit market reflects expansion between 2024 and 2034 at a CAGR of 7.6%.
- France preterm birth diagnostic examination kit industry denotes a CAGR of 7.5% between 2024 and 2034.
- Germany demand revenue of preterm birth diagnostic test kits indicates a CAGR of 7.3% through 2034.
- Japan preterm birth diagnostic test kit market implies expansion at a CAGR of 7.1% through 2034.
- Italy preterm birth diagnostic testing equipment sector imply augmentation at a CAGR of 6.8% between 2024 and 2034.
- Russia sales of preterm birth diagnostic test kits indicate a CAGR of 6.6% from 2024 to 2034.
- Spain preterm birth diagnostic testing equipment industry evinces a CAGR of 6.5% through 2034.
Competitive Landscape:
The preterm birth diagnostic test kit market is somewhat fragmented with the presence of numerous regional vendors. The preterm birth and PROM test kit providers strive to acquire a significant market share by endorsing strategies, like collaborations, investments, and mergers and acquisitions. The manufacturers spend on the innovation of enhanced and productive preterm birth diagnostic test kit solutions. The preterm birth diagnostic testing instruments vendors emphasize sustaining competitive rates.
Recent Progressions:
- Natera, Inc. declared the acquisition from Invitae, a dominating medical genetics company, of assets associated with Invitae’s non-invasive prenatal screening and carrier screening firm in January 2024.
- In March 2023, Bio-Rad Laboratories, Inc. announced the acquisition of Diagnostics Development Corporation (DDC) at a cost of USD 1.2 billion.
- Illumina, Inc. purchased Grail, Inc. for USD 8 billion in February 2023.
- Natera, Inc. bought Verinata Health, Inc. in January 2023 for USD 1.9 billion.
Essential Preterm Birth Diagnostic Test Kit Manufacturers:
- Qiagen
- Medix Biochemica
- Hologic Inc.
- Sera Prognostics
- IQ Products
- Creative Diagnostics
- Nanjing Liming Biological Preparations Co., Ltd.
- Clinical Innovations, LLC
- Bioserv Diagnostic GmbH
Key Segments of Preterm Birth Diagnostic Test Kit Market Report:
By Product:
The report consists of key products like ffN test, PAMG-1 test, and IGFBP-1 test.
By Sample:
The market is trifurcated into blood, urine, and vaginal discharge.
By End User:
Key end users present in the industry include hospitals, diagnostic laboratories, outpatient clinics, and research centers.
By Region:
Analysis of the market has been carried out in key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
